ArticleDevelopment (Cambridge, England)2022

Nucleolin loss of function leads to aberrant Fibroblast Growth Factor signaling and craniofacial anomalies.

Soma Dash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.